Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$349.30
+1.09%
Mkt Cap $10.56B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (14 analysts)
$336.40
Range $300.00 – $371.00
Implied Upside
-3.7%
Consensus $336.40 vs current $349.30
NASDAQ·Healthcare·Biotechnology
$349.30
+1.09%
Mkt Cap $10.56B
Buy
10
Hold
0
Sell
0
Price Target (14 analysts)
$336.40
Range $300.00 – $371.00
-3.7%
Consensus $336.40 vs current $349.30